Bryan Lawrence
Member, Board of Directors @Cingulate Inc
Signup · Get unlimited contacts
WORK HISTORY
Member, Board of Directors @Cingulate Inc
Kansas City, KS, US
Cingulate Inc.(NASDAQ: CING), is a biopharmaceutical company utilizing its proprietary PTR drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of ADHD, Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates, including to treat anxiety disorders.
EDUCATION
The Wharton School
MBA, General Management
The University of Kansas
Doctor of Pharmacy (PharmD), Pharmacy
University of South Carolina
Research Fellowship, Glaxo Pharmacoeconomics Fellowship
SKILLS
ABOUT BRYAN LAWRENCE
Specialties: Marketing, Philanthropy, Pharmaceuticals
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.